News & Articles

With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis

Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus

Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

The partnership aims to launch a ready-to-go processing solution that streamlines viral DNA/RNA extraction

Recent funding from the BARDA award helped the company accelerate development and validation

The scientific community is working at full speed to fight the severe acute respiratory syndrome

Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines

The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19

The collaboration aims to develop novel, targeted treatments to address significant unmet needs

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic